Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

The mission

The overarching goal for the Molecular Neuromodulation team is to bring together frontline gene-based technologies with in vivo gene transfer, behavioral and cognitive assessments in disease models of Parkinson’s disease and related disorders for the development of clinical therapies for tomorrow. 

Towards this ultimate goal, the team works along three major areas of research, briefly outlined  in the lnks below.

Molecular Neuromodulation unit
Wallenberg Neuroscience Center
Department of Experimental Medical Science
BMC A10, 221 84 Lund, Sweden
Phone: +46 46 222 68 36
e-Mail: tomas [dot] bjorklund [at] med [dot] lu [dot] se